Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Godoy

Showing results (171-180 of 209) with videos related to

Pageof 21
Sort By:
Current Pharmaceutical Biotechnology|March 21, 2019
Vancomycin Therapeutic Regime Adjustment in Newborns and Infants with Bacterial Infection: Case SeriesNadielle S Bidu, Bruno J D Fernandes, Eduardo J C Dias, et al.
Circulation. Population Health and Outcomes|February 16, 2026
Patterns and Outcomes of Completeness of Revascularization in Patients With Diabetes and Non-ST-Segment-Elevation Myocardial Infarction in Ontario, CanadaLucas C Godoy, Michael E Farkouh, Peter C Austin, et al.
Drugs|June 21, 2020
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI TrialJosé C Nicolau, Deepak L Bhatt, Stefan H Hohnloser, et al.
Journal of the American College of Cardiology|November 6, 2020
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary RevascularizationMichael E Farkouh, Lucas C Godoy, Maria M Brooks, et al.
Lupus|March 19, 2011
PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathwayD S Oxer, L C Godoy, E Borba, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 1, 2018
Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytesJoseph C Godoy, Ingrid R Niesman, Anna R Busija, et al.
JACC. Advances|July 25, 2025
Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention: A Cohort StudyWade Thompson, Irene Jeong, Shalane Basque, et al.
Arquivos Brasileiros De Cardiologia|August 15, 2019
Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019Carlos V Serrano, Alexandre de M Soeiro, Tatiana C A Torres Leal, et al.
Journal of the American College of Cardiology|March 4, 2022
Anticoagulation in Patients With COVID-19: JACC Review Topic of the WeekMichael E Farkouh, Gregg W Stone, Anuradha Lala, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 5, 2024
On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19Lana Wahid, Joshua D Froess, Thomas L Ortel, et al.
Pageof 21

Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
Current Pharmaceutical Biotechnology|March 21, 2019
Vancomycin Therapeutic Regime Adjustment in Newborns and Infants with Bacterial Infection: Case SeriesNadielle S Bidu, Bruno J D Fernandes, Eduardo J C Dias, et al.
Circulation. Population Health and Outcomes|February 16, 2026
Patterns and Outcomes of Completeness of Revascularization in Patients With Diabetes and Non-ST-Segment-Elevation Myocardial Infarction in Ontario, CanadaLucas C Godoy, Michael E Farkouh, Peter C Austin, et al.
Drugs|June 21, 2020
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI TrialJosé C Nicolau, Deepak L Bhatt, Stefan H Hohnloser, et al.
Journal of the American College of Cardiology|November 6, 2020
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary RevascularizationMichael E Farkouh, Lucas C Godoy, Maria M Brooks, et al.
Lupus|March 19, 2011
PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathwayD S Oxer, L C Godoy, E Borba, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 1, 2018
Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytesJoseph C Godoy, Ingrid R Niesman, Anna R Busija, et al.
JACC. Advances|July 25, 2025
Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention: A Cohort StudyWade Thompson, Irene Jeong, Shalane Basque, et al.
Arquivos Brasileiros De Cardiologia|August 15, 2019
Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019Carlos V Serrano, Alexandre de M Soeiro, Tatiana C A Torres Leal, et al.
Journal of the American College of Cardiology|March 4, 2022
Anticoagulation in Patients With COVID-19: JACC Review Topic of the WeekMichael E Farkouh, Gregg W Stone, Anuradha Lala, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 5, 2024
On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19Lana Wahid, Joshua D Froess, Thomas L Ortel, et al.
Pageof 21